Kalenak Jeffrey W

Performance and Safety of a New Ab Interno Gelatin Stent in Refractory Glaucoma at 12 Months.

The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes.

Both implants were effective in reducing IOP and the need for glaucoma medications.